About Brainsbioceutical
Brainsbioceutical is a company based in Vancouver (Canada). Brainsbioceutical has raised $61.9 million across 2 funding rounds from investors including dsm-firmenich, Canaccord Genuity Group and Cannabis Europe.
- Headquarter Vancouver, Canada
- SectorsConsumer
- Email••••••••
- Phone•••• ••••
- Website brainsbioceutical.com
- Social LinkedIn X
- Total Equity Funding$61.9M (USD)
in 2 rounds
- Latest Funding Round$31.9M (USD), Series B
Jun 2021
- Investorsdsm-firmenich
& 2 more
Funding Insights of Brainsbioceutical
Brainsbioceutical has successfully raised a total of $61.9M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $31.9 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61.9M
- Total Rounds 2
- Last Round Series B — $31.9M
- First Round $30M
(Dec 2019)
- Investors Count 3
All 2 funding rounds of Brainsbioceutical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $31.9M | Series B | – | DSM | – |
| Dec 2019 | $30M | Series A | – | Canaccord Genuity Group |
3 investors in total: 3 institutional.
Investors in Brainsbioceutical
Brainsbioceutical has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include dsm-firmenich, Canaccord Genuity Group and Cannabis Europe.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health, nutrition, and bioscience solutions are delivered worldwide. | 1902 | dsm.com | Heerlen, Netherlands | |
Merger and acquisitions advisory firm | 1950 | canaccordgenuity.com | Toronto, Canada | |
Cannabis Europe is recognized as an advocacy group for medical cannabis. | 2018 | cannabiseurope.org | Brussels, Belgium |
Investor details for Brainsbioceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Brainsbioceutical
1 people are tracked at Brainsbioceutical (1 in leadership).
| Name | Role | Group |
|---|---|---|
Rick Brar | Chairman & CEO | Leadership |
Complete people profiles for Brainsbioceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Brainsbioceutical
2 dated milestones of Brainsbioceutical across 2 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round of $30.0M.
- Funding Latest funding round, Series B, of $31.9M.
Similar companies to Brainsbioceutical
10 companies that operate in the same segment as Brainsbioceutical (Cannabis Platforms & Ecosystem Services), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Legal medical and recreational cannabis products are manufactured. | 2016 | Ann Arbor, Michigan, United States | USD 89.95 M | – | 214 | |
Cannabis is cultivated, processed, and retailed by PharmaCann vertically. | 2014 | Oak Park, Illinois, United States | USD 218.7 M | – | 979 | |
Consumer lawn and garden products and services are provided. | 1868 | Columbus, Ohio, United States | – | USD 3.41 B | 5,300 | |
Provider of cannabis dispensaries, cultivators, CPG brands, and services | – | Denver, Colorado, United States | – | USD 172.45 M | – | |
Provider of cannabis based medical and consumer products | 2016 | New York, New York, United States | USD 13.78 M | USD 17.42 M | – | |
Offers medical & wellness cannabis products sourcing and processing services | 2021 | London, England, United Kingdom | USD 5.32 M | USD 258.08 K | 168 | |
Cannabis extracts and white label solutions are provided globally. | 2016 | United States | USD 13.56 M | – | – | |
Cannabis products are produced, cultivated, branded, and processed. | 2017 | New York, New York, United States | – | – | 2,198 | |
Developer of water-soluble cannabinoid extraction technologies | 2018 | Los Alamos, New Mexico, United States | USD 47.59 M | – | – | |
Medicinal cannabis is produced by Blueberries Medical in Colombia. | 2013 | Bogota, Bogota, Colombia | – | USD 228.08 K | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Brainsbioceutical
Brainsbioceutical is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Rick Brar is the current CEO of Brainsbioceutical.
Brainsbioceutical is a funded company, having raised a total of $61.9M across 2 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Dec 2019.
Pharmaceutical-grade cannabinoid active pharmaceutical ingredients are produced by Brainsbioceutical in Vancouver, Canada, for the pharmaceutical and nutraceutical sectors. These ingredients are derived from natural sources. Relevant licenses and certifications are maintained to meet industry standards. A selection of cannabinoid APIs, including CBD and associated compounds, is supplied. Research and development activities are pursued to support cannabinoid applications in medicine.
Brainsbioceutical has 3 investors. Key investors include dsm-firmenich, Canaccord Genuity Group, and Cannabis Europe.